Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Oncology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Cancer/Tumors Clinical Trials

A listing of Cancer/Tumors medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (651) clinical trials

This is a randomized, double-blind, placebo-controlled, multicenter phase III study. The study population will consist of approximately 1300 subjects with metastatic hormone sensitive prostate cancer (mHSPC), who will be randomized (1:1 ratio) to receive 600 mg (2 x 300 mg tablets) of darolutamide (ODM-201)/placebo twice daily with food, equivalent to ...

Phase

People with prostate cancer  and cardiovascular Disease are asked to participate in a research study being conducted by Montefiore Medical Center.  

Phase N/A

People with prostate cancer are asked to participate in a research study being conducted by Montefiore Medical Center.  

Phase N/A

People with small cell neuroendocrine prostate cancer are asked to participate in a research study being conducted by White Plains Hospital.  

Phase N/A

People with Metastatic Castration-resistant Prostate cancer are asked to participate in a research study being conducted by Northwell Health.  

Phase N/A

People with Metastatic Castration-resistant Prostate cancer are asked to participate in a research study being conducted by White Plains Hospital.  

Phase N/A

The Metformin Active Surveillance Trial (MAST) Study

This study aims to see if metformin can delay the time to progression in men with low risk prostate cancer when compared to a placebo.

Phase

Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer

Patients will receive: 62 Gy (RBE) in 20 fractions of 3.1 Gy (RBE) over 4 weeks

Phase

Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer

Radiation therapy is considered a standard treatment option for the management of localized prostate cancer. Among the 20-30% who recur, a proportion of them will present with an isolated local recurrence, meaning no distant metastases. If left untreated, it may serve as a source for subsequent metastases. Salvage options available ...

Phase